Search Articles

View query in Help articles search

Search Results (1 to 10 of 28 Results)

Download search results: CSV END BibTex RIS


Continuous Glucose Monitoring Among Patients With Type 1 Diabetes in Rwanda (CAPT1D) Phase I: Prospective Observational Feasibility Study

Continuous Glucose Monitoring Among Patients With Type 1 Diabetes in Rwanda (CAPT1D) Phase I: Prospective Observational Feasibility Study

In both cases, glucose monitoring is necessary [3] to prevent or treat acute (hypoglycemia, hyperglycemia, and diabetic ketoacidosis [DKA]) or chronic (microvacular and macrovascular) complications, and more frequent monitoring has been shown to have better diabetes outcomes [4].

Jason Baker, Giacomo Cappon, Jean Claude Habineza, Corey H Basch, Steven Mey, Diana L Malkin-Washeim, Christian Schuetz, Niyonsenga Simon Pierre, Etienne Uwingabire, Alvera Mukamazimpaka, Paul Mbonyi, Sandhya Narayanan

JMIR Form Res 2025;9:e64585

Generalization of a Deep Learning Model for Continuous Glucose Monitoring–Based Hypoglycemia Prediction: Algorithm Development and Validation Study

Generalization of a Deep Learning Model for Continuous Glucose Monitoring–Based Hypoglycemia Prediction: Algorithm Development and Validation Study

Although the pathogenic mechanisms of T1 DM and T2 DM are different, glucose-lowering treatments such as insulin administration are the common leading cause of hypoglycemia events in patients with both diabetes subtypes [4]. Severe hypoglycemia is a frequent phenomenon in patients with T1 DM, with an annual prevalence of 30%-40% [5].

Jian Shao, Ying Pan, Wei-Bin Kou, Huyi Feng, Yu Zhao, Kaixin Zhou, Shao Zhong

JMIR Med Inform 2024;12:e56909

Multimodal In-Vehicle Hypoglycemia Warning for Drivers With Type 1 Diabetes: Design and Evaluation in Simulated and Real-World Driving

Multimodal In-Vehicle Hypoglycemia Warning for Drivers With Type 1 Diabetes: Design and Evaluation in Simulated and Real-World Driving

One of the most relevant acute complications associated with T1 DM is hypoglycemia (ie, low blood glucose). This condition is associated with impaired cognitive, executive, and psychomotor function [2-4] and is linked to driving mishaps [5-7]. Previous work introduced the development of a voice warning for hypoglycemia while behind the wheel, whereas the voice assistant (VA) would work as a warning interface [8].

Caterina Bérubé, Martin Maritsch, Vera Franziska Lehmann, Mathias Kraus, Stefan Feuerriegel, Thomas Züger, Felix Wortmann, Christoph Stettler, Elgar Fleisch, A Baki Kocaballi, Tobias Kowatsch

JMIR Hum Factors 2024;11:e46967

Effectiveness and User Perception of an In-Vehicle Voice Warning for Hypoglycemia: Development and Feasibility Trial

Effectiveness and User Perception of an In-Vehicle Voice Warning for Hypoglycemia: Development and Feasibility Trial

Hypoglycemia, also known as low blood glucose, is a frequent and acute complication in patients with T1 DM [2,3]. Symptoms range from autonomic reactions such as trembling, anxiety, and hunger (ie, mild hypoglycemia) to neuroglycopenic reactions such as vision impairment, weakness, or cognitive impairments (ie, severe hypoglycemia) [2,4-6]. Hypoglycemia is a major issue in the context of driving: research has shown that hypoglycemia is associated with a higher risk of car mishaps [7-9].

Caterina Bérubé, Vera Franziska Lehmann, Martin Maritsch, Mathias Kraus, Stefan Feuerriegel, Felix Wortmann, Thomas Züger, Christoph Stettler, Elgar Fleisch, A Baki Kocaballi, Tobias Kowatsch

JMIR Hum Factors 2024;11:e42823

Machine Learning Models for Blood Glucose Level Prediction in Patients With Diabetes Mellitus: Systematic Review and Network Meta-Analysis

Machine Learning Models for Blood Glucose Level Prediction in Patients With Diabetes Mellitus: Systematic Review and Network Meta-Analysis

Adverse blood glucose (BG) events are one of the most common short-term complications, including hypoglycemia with BG180 mg/d L. Hyperglycemia in patients with DM may lead to lower limb occlusions and extremity nerve damage, further leading to decay, necrosis, and local or whole-foot gangrene, even requiring amputation [8,9]. Hypoglycemia can cause serious symptoms, including anxiety, palpitation, and confusion in a mild scenario and seizures, coma, and even death in a severe scenario [10,11].

Kui Liu, Linyi Li, Yifei Ma, Jun Jiang, Zhenhua Liu, Zichen Ye, Shuang Liu, Chen Pu, Changsheng Chen, Yi Wan

JMIR Med Inform 2023;11:e47833

An mHealth Text Messaging Program Providing Symptom Detection Training and Psychoeducation to Improve Hypoglycemia Self-Management: Intervention Development Study

An mHealth Text Messaging Program Providing Symptom Detection Training and Psychoeducation to Improve Hypoglycemia Self-Management: Intervention Development Study

Unhelpful hypoglycemia beliefs that can contribute to poor self-management include the following: minimal hypoglycemia risk perceptions; high perceptions of hyperglycemia and social risks from hypoglycemia self-management (which can lead to low hypoglycemia self-management outcome expectancies); and low hypoglycemia management coping efficacy [33,39,40].

Yu Kuei Lin, James E Aikens, Nicole de Zoysa, Diana Hall, Martha Funnell, Robin Nwankwo, Kate Kloss, Melissa J DeJonckheere, Rodica Pop-Busui, Gretchen A Piatt, Stephanie A Amiel, John D Piette

JMIR Form Res 2023;7:e50374

Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study

Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study

Hypoglycemia, or low blood glucose, is a common complication of insulin treatment among people with type 1 diabetes mellitus (T1 DM) and insulin-treated type 2 diabetes mellitus (T2 DM). Hypoglycemia can result in neurocognitive impairment [1] and can be debilitating, adversely affecting multiple aspects of quality of life (eg, work life and relationships) for people with diabetes and their family members [2-4].

Uffe Søholm, Natalie Zaremba, Melanie Broadley, Johanne Lundager Axelsen, Patrick Divilly, Gilberte Martine-Edith, Stephanie A Amiel, Julia K Mader, Ulrik Pedersen-Bjergaard, Rory J McCrimmon, Eric Renard, Mark Evans, Bastiaan de Galan, Simon Heller, Christel Hendrieckx, Pratik Choudhary, Jane Speight, Frans Pouwer, Hypo-RESOLVE consortium Hypo-RESOLVE consortium

JMIR Diabetes 2023;8:e42100

Long-Term Benefits of an Integrated Continuous Glucose Monitoring and Insulin Pump System for Emergency Admissions, Hospitalization, and Metabolic Control in a Cohort of People With Diabetes: Retrospective Cohort Study

Long-Term Benefits of an Integrated Continuous Glucose Monitoring and Insulin Pump System for Emergency Admissions, Hospitalization, and Metabolic Control in a Cohort of People With Diabetes: Retrospective Cohort Study

The current American Diabetes Association (ADA) and International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines recommend the therapeutic goal of glycated hemoglobin (Hb A1c) With recent advances over the last few years, such as better safety profiles in insulin pharmacokinetics and new diabetes devices, the risk of hypoglycemia has been reduced, and patients have been able to achieve better Hb A1c goals [7-12].

Miguel O'Meara, Juan Camilo Mateus Acuña, Andrea Uribe

JMIR Diabetes 2023;8:e46880

Using Continuous Glucose Monitoring and Data Sharing to Encourage Collaboration Among Older Adults With Type 1 Diabetes and Their Care Partners: Qualitative Descriptive Study

Using Continuous Glucose Monitoring and Data Sharing to Encourage Collaboration Among Older Adults With Type 1 Diabetes and Their Care Partners: Qualitative Descriptive Study

Older adults living with T1 D often experience age-related changes including increasing hypoglycemia accompanied by hypoglycemia unawareness [4]. Severe hypoglycemia in older adults can lead to loss of consciousness, seizures, falls, and other complications such as myocardial infarction [5-7]. However, technology such as continuous glucose monitoring (CGM) has recently been shown to be effective in reducing hypoglycemia and hyperglycemia in older adults with T1 D [8,9].

Alycia A Bristol, Michelle Litchman, Cynthia Berg, Ernest Grigorian, Denise Small, Ashley Glazener, Christopher Jones, Nancy A Allen

JMIR Nursing 2023;6:e46627